A Novel CpG Methylation Risk Indicator for Predicting Prognosis in Bladder Cancer

PURPOSE: Bladder cancer (BLCA) is one of the most common cancers worldwide. In a large proportion of BLCA patients, disease recurs and/or progress after resection, which remains a major clinical issue in BLCA management. Therefore, it is vital to identify prognostic biomarkers for treatment stratifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yufeng, Yin, Jianjian, Dai, Yuanheng, Guan, Yudong, Chen, Pinjin, Chen, Yongqiang, Huang, Chenzheng, Lu, Yong-Jie, Zhang, Lirong, Song, Dongkui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440888/
https://www.ncbi.nlm.nih.gov/pubmed/34540821
http://dx.doi.org/10.3389/fcell.2021.642650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440888/
https://www.ncbi.nlm.nih.gov/pubmed/34540821
http://dx.doi.org/10.3389/fcell.2021.642650

Ejemplares similares